Mediastinal Staging of Lung Cancer With EBUS-TBNA and EUS-B-FNA
Not Applicable
Completed
- Conditions
- Lung Cancer
- Registration Number
- NCT00741247
- Lead Sponsor
- National Cancer Center, Korea
- Brief Summary
The purpose of this study is to find a role of EUS-B-FNA in the mediastinal staging of potentially operable lung cancer. The investigators perform EBUS-TBNA and EUS-B-FNA on potentially operable lung cancer patients. The investigators perform EBUS(+/- TBNA) and EUS-B (ultrasonographic examination through the esophagus) on all subjects. EUS-B-FNA will be performed on inaccessible nodes or difficult nodes to be sampled by EBUS-TBNA. Additional diagnostic values of EUS-B-FNA as compared to EBUS-TBNA alone will be estimated.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
- Histologically confirmed or strongly suspected potentially operable non-small cell lung cancer (NSCLC)
- Potentially operable patients
Exclusion Criteria
After staging work-up for NSCLC, including bronchoscopy,CT of the chest and upper abdomen, integrated PET/CT and brain MRI (and/or bone scan)
- M1 disease
- Inoperable T4 disease
- Mediastinal infiltration or extranodal invasion of the mediastinal lymph node visible on chest CT.
- Confirmed supraclavicular lymph node metastasis
- Pancoast tumors
- Medically inoperable patients
- Contraindications for bronchoscopy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method The diagnostic values of EBUS-TBNA plus EUS-B-FNA as compared to EBUS-TBNA alone June 2009
- Secondary Outcome Measures
Name Time Method The Proportion and the location of lymph nodes accessible by EBUS-TBNA and EUS-B-FNA. June 2009
Trial Locations
- Locations (1)
NCCKorea
🇰🇷Gyeonggi-do, Korea, Republic of